These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 8229233

  • 1. Biodistribution and dosimetry of iodine-123-IBF: a potent radioligand for imaging the D2 dopamine receptor.
    Mozley PD, Stubbs JB, Kung HF, Selikson MH, Stabin MG, Alavi A.
    J Nucl Med; 1993 Nov; 34(11):1910-7. PubMed ID: 8229233
    [Abstract] [Full Text] [Related]

  • 2. Dosimetry of a D2/D3 dopamine receptor antagonist that can be used with PET or SPECT.
    Mozley PD, Stubbs JB, Kim HJ, McElgin W, Chumpradit S, Kung MP, Romaniello G, Kung HF.
    J Nucl Med; 1995 Jul; 36(7):1322-31. PubMed ID: 7790963
    [Abstract] [Full Text] [Related]

  • 3. Human biodistribution and dosimetry of the SPECT D2 dopamine receptor radioligand [123I]IBF.
    van Dyck CH, Seibyl JP, Stubbs JB, Zoghbi S, Wisniewski G, Baldwin RM, Zea-Ponce Y, Charney DS, Hoffer PB, Innis RB.
    Nucl Med Biol; 1996 Jan; 23(1):9-16. PubMed ID: 9004921
    [Abstract] [Full Text] [Related]

  • 4. The dosimetry of iodine-123-labeled TISCH: a SPECT imaging agent for the D1 dopamine receptor.
    Mozley PD, Zhu X, Kung HF, Selikson MH, Hickey J, Galloway S, Pfieffer N, Alavi A.
    J Nucl Med; 1993 Feb; 34(2):208-13. PubMed ID: 8429338
    [Abstract] [Full Text] [Related]

  • 5. Dosimetry of iodine-123-epidepride: a dopamine D2 receptor ligand.
    Votaw JR, Ansari MS, Mason NS, Schmidt D, de Paulis T, Holburn G, Clanton JA, Votaw DB, Manning RG, Kessler RM.
    J Nucl Med; 1995 Jul; 36(7):1316-21. PubMed ID: 7790962
    [Abstract] [Full Text] [Related]

  • 6. Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects.
    Laruelle M, van Dyck C, Abi-Dargham A, Zea-Ponce Y, Zoghbi SS, Charney DS, Baldwin RM, Hoffer PB, Kung HF, Innis RB.
    J Nucl Med; 1994 May; 35(5):743-54. PubMed ID: 8176454
    [Abstract] [Full Text] [Related]

  • 7. [Phase 1 clinical study of 123I-IBF, a new radioligand for evaluating dopamine D2 receptor with SPECT (I); biodistribution and dosimetry].
    Yonekura Y, Sadato N, Tsuchida T, Uematsu H, Nakamura S, Yamamoto K, Ishii Y.
    Kaku Igaku; 1999 Feb; 36(2):145-53. PubMed ID: 10213982
    [Abstract] [Full Text] [Related]

  • 8. Radiation dosimetry of a 99mTc-labeled IgM murine antibody to CD15 antigens on human granulocytes.
    Mozley PD, Stubbs JB, Dresel SH, Barraclough ED, Smith T, Patel M, Finkelman C, Sparks RB, Thakur ML, Mathur A, Alavi A.
    J Nucl Med; 1999 Apr; 40(4):625-30. PubMed ID: 10210221
    [Abstract] [Full Text] [Related]

  • 9. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.
    Lahorte CM, van de Wiele C, Bacher K, van den Bossche B, Thierens H, van Belle S, Slegers G, Dierckx RA.
    Nucl Med Commun; 2003 Aug; 24(8):871-80. PubMed ID: 12869819
    [Abstract] [Full Text] [Related]

  • 10. Dosimetry of an iodine-123-labeled tropane to image dopamine transporters.
    Mozley PD, Stubbs JB, Kim HJ, McElgin W, Kung MP, Meegalla S, Kung HF.
    J Nucl Med; 1996 Jan; 37(1):151-9. PubMed ID: 8543985
    [Abstract] [Full Text] [Related]

  • 11. Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results.
    Kauppinen TA, Bergström KA, Heikman P, Hiltunen J, Ahonen AK.
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):132-6. PubMed ID: 12483421
    [Abstract] [Full Text] [Related]

  • 12. Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PET.
    Slifstein M, Hwang DR, Martinez D, Ekelund J, Huang Y, Hackett E, Abi-Dargham A, Laruelle M.
    J Nucl Med; 2006 Feb; 47(2):313-9. PubMed ID: 16455638
    [Abstract] [Full Text] [Related]

  • 13. Fluorine-18-fluoro-L-DOPA dosimetry with carbidopa pretreatment.
    Brown WD, Oakes TR, DeJesus OT, Taylor MD, Roberts AD, Nickles RJ, Holden JE.
    J Nucl Med; 1998 Nov; 39(11):1884-91. PubMed ID: 9829576
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Phase 1 clinical study of 123I-IBF, a new radioligand for evaluating Dopamine D2 receptor with SPECT (II); pharmacokinetics study and quantification in the brain].
    Yonekura Y, Sadato N, Tsuchida T, Uematsu H, Nakamura S, Onishi Y, Yamamoto K, Ishii Y.
    Kaku Igaku; 1999 Feb; 36(2):155-68. PubMed ID: 10213983
    [Abstract] [Full Text] [Related]

  • 17. 1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation.
    Virta JR, Tolvanen T, Någren K, Brück A, Roivainen A, Rinne JO.
    J Nucl Med; 2008 Mar; 49(3):347-53. PubMed ID: 18287260
    [Abstract] [Full Text] [Related]

  • 18. Patient dosimetry of intravenously administered 99mTc-annexin V.
    Kemerink GJ, Liem IH, Hofstra L, Boersma HH, Buijs WC, Reutelingsperger CP, Heidendal GA.
    J Nucl Med; 2001 Feb; 42(2):382-7. PubMed ID: 11216539
    [Abstract] [Full Text] [Related]

  • 19. Biodistribution and radiation dosimetry of 18F-fluoro-A-85380 in healthy volunteers.
    Bottlaender M, Valette H, Roumenov D, Dollé F, Coulon C, Ottaviani M, Hinnen F, Ricard M.
    J Nucl Med; 2003 Apr; 44(4):596-601. PubMed ID: 12679405
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.